CuO@ZnO core-shell catalysts, coated by varying the CuO layer density ranging from 0.5% to 10%, were synthesized with the aim to enhance the photocatalytic activity of ZnO in sunlight and control its photocorrosion. Initially, the Cu(2+) ions were impregnated on presynthesized ZnO by wet impregnation and finally converted to CuO layers by calcination. The optical and structural characterization of the synthesized powders was performed by DRS, PL, Raman spectroscopy, and XRD analysis, respectively. The homogeneity of the coated layers was explored by FESEM. The photocatalytic activity of CuO coated ZnO was investigated for the degradation of mononitrophenols (2-, 3-, and 4-nitrophenol) and dinitrophenols (2,4-, 2,5-, and 2,6-dinitrophenol) in the exposure of the complete spectrum and visible region (420-800 nm) of sunlight. The effect of the increasing density coated layers of CuO on photocatalytic activity was evaluated for the degradation of 4-NP. Compared to pristine ZnO, a substantial increase in the degradation/mineralization ability was observable for the catalysts coated with 0.5% and 1% CuO, whereas a detrimental effect was noticed for higher coating density. Prior to photocatalytic studies, as evaluated by cyclic voltammetry (CV), compared to pure ZnO, a significant suppression of photocorrosion was noticed, under illumination, for catalysts coated with lower CuO coating. The progress of the photocatalytic degradation process was monitored by HPLC while the mineralization ability of the synthesized catalysts was estimated by TOC. The estimation of the released ions and their further interaction with the excited states and the reactive oxygen was monitored by ion chromatography (IC).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.